MLchartDataset catalogue

gp96 HSP-peptide complex

Term · Oncology and biomedicine · MLC-T-ONC-003638

A vaccine made from a patient’s tumor cells that may help the body’s immune system kill cancer cells. This vaccine is used to treat kidney cancer, a type of brain cancer called glioma, and metastatic melanoma (a type of skin cancer that has spread). It is also being studied in the treatment of other types of cancer. Also called gp96 heat shock protein-peptide complex vaccine, Oncophage, and vitespen.

Table 1. Record
IdentifierMLC-T-ONC-003638
FieldOncology and biomedicine
Synonymsgp96 heat shock protein-peptide complex vaccine; Oncophage; vitespen
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003638",
  "term": "gp96 HSP-peptide complex",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine made from a patient’s tumor cells that may help the body’s immune system kill cancer cells. This vaccine is used to treat kidney cancer, a type of brain cancer called glioma, and metastatic melanoma (a type of skin cancer that has spread). It is also being studied in the treatment of other types of cancer. Also called gp96 heat shock protein-peptide complex vaccine, Oncophage, and vitespen.",
  "synonyms": [
    "gp96 heat shock protein-peptide complex vaccine",
    "Oncophage",
    "vitespen"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/gp96-hsp-peptide-complex/"
}

Record 8,149 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.